Odyssey Health, Inc. (ODYY) Form 10-Q — Jun 12, 2026

Odyssey Health reported a net loss of $3.3 million for the nine months ended April 30, 2026, driven by $3.1 million in financing costs and $1 million in interest expense, despite a $1.5 million gain from the change in fair value of derivative liabilities. The company generated no revenue, holding only $297,806 in cash against $10.1 million in current liabilities, resulting in a $9.7 million working capital deficit. Management disclosed substantial doubt about the company’s ability to continue as a going concern, stating that continued existence depends on raising additional capital.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.